(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BYONSHIELD

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

BYONSHIELD

ST13

US500000090383422

Class

42

Filing

90383422

Registration

6586929

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

19

Latest update

11/21/2022

Trademark type

Word

Nice classes

42

Filing date

12/15/2020

Registration date

12/14/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/14/2021

Last transaction

12/14/2021

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

4

Owner type

16

Owner location

6545 CM, NL

Examiner

I, DAVID C

Law office

M50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

BYONDIS B.V.

Representatives

E. Anthony Figg ROTHWELL FIGG ERNST & MANBECK PC

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Scientific and technological servicesscientific researchanalysistestingdiagnostic testing in the field of medicinecancers and autoimmune diseasesthe treatment of illnesses; Pharmaceutical research and development; biomedical research; medical research; scientific chemical and biological laboratory services; scientific laboratory services relating to pharmaceuticals; Development of pharmaceutical products and ingredients; laboratory research and analysischemical research and analysisbiological research and analysis; research and design services for the pharmaceutical industry; research and development of new products for others; research into new drugspharmaceutical drug development services; research and design services for the pharmaceutical industry; research and development of new products for others; research into new drugspharmaceutical drug development services; Scientific research in the field of proteinsantibodiesmicroorganisms and cells; Scientific research and development in antibody technology; design and development of medical technologies; research and development of antibody conjugates combined with a drug or chemical for the treatment of cancer

Publications

History of USPTO decisions and trademark events.

19 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/21/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

11/21/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

11/21/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

11/21/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

12/14/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/28/2021

PUBO

PUBLISHED FOR OPPOSITION

09/28/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/08/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/24/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/23/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/23/2021

ALIE

ASSIGNED TO LIE

07/22/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/08/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/08/2021

GNRT

NON-FINAL ACTION E-MAILED

06/08/2021

CNRT

NON-FINAL ACTION WRITTEN

06/08/2021

DOCK

ASSIGNED TO EXAMINER

06/08/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/23/2021

NWAP

NEW APPLICATION ENTERED

12/18/2020

Continuous trademark protection

Get notified about every new filing that threatens BYONSHIELD or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.